Your session is about to expire
← Back to Search
Other
Acetaminophen for Radical Prostatectomy
Phase 2 & 3
Waitlist Available
Led By Ashok K Hemal, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
All men ages 40-75 undergoing bilateral robot assisted radical prostatectomy (RARP) with bilateral lymph node dissection with low-intermediate to high-risk localized prostate cancer
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 7
Awards & highlights
Study Summary
This study is evaluating whether a non-opioid pain medication can be used to reduce pain after prostatectomies.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 7
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 7
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Pharmaceutical Preparations
Fetal Distress
Pain
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental CohortExperimental Treatment5 Interventions
Multimodal Approach:
Gabapentin (100mg TID) Ketorolac (15mg q6) Acetaminophen (1mg IV q6) Ketamine (1.5mg/kg) Ketorolac tromethamine (15mg or 30mg Q4)
Group II: Opioid Control CohortActive Control3 Interventions
One treatment selected:
Tramadol (50mg) Hydrocodone-Acetaminophen (2.5mg/325mg) Oxycodone-Acetaminophen (2.5mg/325mg)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ketamine
2011
Completed Phase 4
~1090
Acetaminophen
2017
Completed Phase 4
~2030
Ketorolac tromethamine
2006
Completed Phase 3
~950
Ketorolac
2014
Completed Phase 4
~1760
Gabapentin
2013
Completed Phase 4
~1550
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,241 Previous Clinical Trials
1,004,237 Total Patients Enrolled
Ashok K Hemal, MDPrincipal InvestigatorWake Forest Health Sciences
1 Previous Clinical Trials
Ram Pathak, MDPrincipal InvestigatorWake Forest Health Sciences
1 Previous Clinical Trials
62 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger